vs
Side-by-side financial comparison of BARFRESH FOOD GROUP INC. (BRFH) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.
BARFRESH FOOD GROUP INC. is the larger business by last-quarter revenue ($5.4M vs $3.9M, roughly 1.4× Opus Genetics, Inc.). On growth, BARFRESH FOOD GROUP INC. posted the faster year-over-year revenue change (94.5% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs 38.4%).
Barfresh Food Group Inc. is a specialized food and beverage firm that develops, manufactures, and distributes frozen ready-to-blend smoothies, frappes, and related beverage products. Its core client base includes quick service restaurants, K-12 schools, healthcare facilities, and hospitality operators across North America, delivering portion-controlled, easy-to-prepare solutions that cut down on front-of-house preparation work for food service partners.
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
BRFH vs IRD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.4M | $3.9M |
| Net Profit | $-763.0K | — |
| Gross Margin | 2.9% | — |
| Operating Margin | -28.9% | — |
| Net Margin | -14.1% | — |
| Revenue YoY | 94.5% | -10.2% |
| Net Profit YoY | 10.4% | 53.0% |
| EPS (diluted) | $-0.04 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.4M | $3.9M | ||
| Q3 25 | $4.2M | $3.1M | ||
| Q2 25 | $1.6M | $2.9M | ||
| Q1 25 | $2.9M | $4.4M | ||
| Q4 24 | $2.8M | $4.3M | ||
| Q3 24 | $3.6M | $3.9M | ||
| Q2 24 | $1.5M | $1.1M | ||
| Q1 24 | $2.8M | $1.7M |
| Q4 25 | $-763.0K | — | ||
| Q3 25 | $-290.0K | $-17.5M | ||
| Q2 25 | $-880.0K | $-7.4M | ||
| Q1 25 | $-761.0K | $-8.2M | ||
| Q4 24 | $-852.0K | — | ||
| Q3 24 | $-513.0K | $-7.5M | ||
| Q2 24 | $-1.0M | $-7.8M | ||
| Q1 24 | $-449.0K | $-7.1M |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 36.7% | — | ||
| Q2 25 | 31.1% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 26.2% | — | ||
| Q3 24 | 34.6% | — | ||
| Q2 24 | 34.8% | — | ||
| Q1 24 | 41.4% | — |
| Q4 25 | -28.9% | — | ||
| Q3 25 | -6.1% | -269.9% | ||
| Q2 25 | -53.4% | -309.0% | ||
| Q1 25 | -25.2% | -227.2% | ||
| Q4 24 | -29.5% | — | ||
| Q3 24 | -13.7% | -207.1% | ||
| Q2 24 | -68.6% | -748.9% | ||
| Q1 24 | -15.8% | -450.5% |
| Q4 25 | -14.1% | — | ||
| Q3 25 | -6.9% | -566.9% | ||
| Q2 25 | -54.2% | -257.5% | ||
| Q1 25 | -26.0% | -187.5% | ||
| Q4 24 | -30.6% | — | ||
| Q3 24 | -14.1% | -194.6% | ||
| Q2 24 | -69.1% | -698.3% | ||
| Q1 24 | -15.9% | -415.3% |
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $-0.02 | $-0.25 | ||
| Q2 25 | $-0.06 | $-0.12 | ||
| Q1 25 | $-0.05 | $-0.24 | ||
| Q4 24 | $-0.06 | — | ||
| Q3 24 | $-0.03 | $-0.29 | ||
| Q2 24 | $-0.07 | $-0.30 | ||
| Q1 24 | $-0.03 | $-0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $45.1M |
| Total DebtLower is stronger | $766.0K | — |
| Stockholders' EquityBook value | $1.3M | $15.3M |
| Total Assets | $12.8M | $50.2M |
| Debt / EquityLower = less leverage | 0.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $45.1M | ||
| Q3 25 | — | $30.8M | ||
| Q2 25 | — | $32.4M | ||
| Q1 25 | — | $41.8M | ||
| Q4 24 | — | $30.3M | ||
| Q3 24 | — | $36.6M | ||
| Q2 24 | — | $41.4M | ||
| Q1 24 | $1.2M | $47.2M |
| Q4 25 | $766.0K | — | ||
| Q3 25 | $596.0K | — | ||
| Q2 25 | $176.0K | — | ||
| Q1 25 | $200.0K | — | ||
| Q4 24 | $223.0K | — | ||
| Q3 24 | $246.0K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.3M | $15.3M | ||
| Q3 25 | $1.9M | $6.0M | ||
| Q2 25 | $2.0M | $17.5M | ||
| Q1 25 | $2.8M | $5.1M | ||
| Q4 24 | $578.0K | $6.7M | ||
| Q3 24 | $1.4M | $34.3M | ||
| Q2 24 | $1.7M | $40.6M | ||
| Q1 24 | $2.5M | $46.1M |
| Q4 25 | $12.8M | $50.2M | ||
| Q3 25 | $6.8M | $36.1M | ||
| Q2 25 | $3.8M | $38.7M | ||
| Q1 25 | $5.3M | $48.2M | ||
| Q4 24 | $3.3M | $36.9M | ||
| Q3 24 | $3.8M | $40.4M | ||
| Q2 24 | $3.3M | $44.8M | ||
| Q1 24 | $4.7M | $51.8M |
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.09× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.39× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $507.0K | $-35.3M |
| Free Cash FlowOCF − Capex | $426.0K | — |
| FCF MarginFCF / Revenue | 7.9% | — |
| Capex IntensityCapex / Revenue | 1.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $507.0K | $-35.3M | ||
| Q3 25 | $-598.0K | $-6.2M | ||
| Q2 25 | $-1.1M | $-10.3M | ||
| Q1 25 | $-506.0K | $-9.0M | ||
| Q4 24 | $-685.0K | $-25.6M | ||
| Q3 24 | $5.0K | $-5.1M | ||
| Q2 24 | $-780.0K | $-7.3M | ||
| Q1 24 | $-769.0K | $-5.7M |
| Q4 25 | $426.0K | — | ||
| Q3 25 | $-650.0K | — | ||
| Q2 25 | $-1.1M | — | ||
| Q1 25 | $-534.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-52.0K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 7.9% | — | ||
| Q3 25 | -15.4% | — | ||
| Q2 25 | -69.8% | — | ||
| Q1 25 | -18.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 1.5% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRFH
| Raw And Processed Milk | $2.7M | 51% |
| Other | $2.7M | 49% |
IRD
Segment breakdown not available.
